查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1983732

体外诊断包装市场：依包装类型、材料、无菌性、温度需求、最终用户和通路划分－2026-2032年全球市场预测

In-Vitro Diagnostics Packaging Market by Packaging Format, Material, Sterility, Temperature Requirement, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，体外诊断包装市场价值将达到 82.1 亿美元，到 2026 年将成长至 87.6 亿美元，到 2032 年将达到 132.5 亿美元，复合年增长率为 7.07%。

主要市场统计数据
基准年 2025 82.1亿美元
预计年份：2026年 87.6亿美元
预测年份 2032 132.5亿美元
复合年增长率 (%) 7.07%

旨在保障诚信、可追溯性和永续性的策略政策正在改变诊断包装支持临床工作流程和监管期望的方式。

体外诊断包装产业正处于关键的转折点，其驱动力来自加速的创新、日益严格的监管以及对供应链韧性的日益重视。包装的功能不再只是封装和保护；它们是支撑整个检体生命週期中诊断准确性、生物安全性和可追溯性的基石。随着检查室、医院、照护现场(PoC) 服务供应商和研究机构不断拓展其检测方法，对包装解决方案的需求格局也迅速多元化。这种转变迫使製造商和采购团队重新思考材料选择、无菌性和端到端低温运输能力，以维持检体完整性并确保患者安全。

整合製造、先进材料和数位可追溯性正在融合，重新定义包装在诊断准确性、物流和采购管道中的作用。

该领域正经历变革性的转变，重塑着竞争动态和营运重点。无菌加工技术的进步，例如吹灌封 (BFS) 系统和整合式卡匣生产，在提高加工能力的同时降低了污染风险；而柔性包装的创新则优化了运输重量和储存效率。这些工艺层面的创新与材料科学的突破相辅相成。特种聚合物和复合材料稳定性层压材料的出现，提升了阻隔性和耐热性，使其应用范围更广，能够适应常温、冷藏和冷冻等多种温度环境。因此，包装正从被动的保护手段转变为支持诊断性能和物流效率的主动要素。

关税调整和贸易政策变化促使供应链重组和区域生产投资，以确保诊断包装的连续性和合规性。

2025年美国加征关税和调整贸易政策，对原材料和成品诊断包装的进口造成了巨大压力，促使製造商和买家迅速采取战略应对措施。关税导致成本增加，加速了对供应商中心和合约条款的重新评估，尤其是那些来自全球供应链的零件和材料。在此背景下，供应链图谱绘製、供应商风险评估以及寻找既能确保屏障性能和无菌性又不影响监管合规性的替代原材料，变得比以往任何时候都更加迫切。

按格式、材料、最终用户、无菌性、温度和分销等类别进行详细细分，可以揭示诊断包装的目标产品和基本市场准入要求。

市场区隔揭示了不同的需求模式和技术要求，这些都指南产品开发和商业化策略。从包装趋势来看，吹灌封 (BFS) 解决方案，特别是安瓿瓶和卡式包装盒，在对无菌性、精确剂量和整合填充要求极高的应用中备受青睐。同时，薄膜复合材料和软包装袋等软质包装则支持试剂的大量分销和轻量化运输。包括微孔盘载玻片和试管管瓶在内的硬质包装仍然是检查室自动化和检体储存的核心，人们正在不断优化其设计，以提高操作的便利性和仪器相容性。

区域间在监管重点、生产能力和低温运输成熟度方面的差异，决定了诊断包装部署策略方法的差异。

区域趋势凸显了影响製造地、监管策略和物流投资的许多优先事项。在美洲，需求集中在先进的实验室基础设施和即时检测 (POC) 部署上，从而对无菌、自动化硬质包装产品产生了强劲的需求，并对冷藏和常温解决方案保持持续的需求。该地区的监管环境和采购週期正在推动对国内或近岸生产的投资，尤其是在政策变化导致进口成本上升或供应稳定至关重要的地区。

为了确保竞争优势，各公司都在加强无菌生产能力、材料创新和数位化可追溯性，同时扩大服务范围并提高区域产量。

诊断包装领域的主要企业正在推行多元化的竞争策略，将技术投资与业务重组结合。许多企业正在提升其无菌加工和吹灌封 (BFS) 系统的能力，以降低污染风险并提高无菌一次性产品的生产效率。同时，材料创新专案正着力研发特种聚合物和层压结构，以实现可回收性和材料减量化，同时改善阻隔性和热稳定性。此外，各企业也正在投资数位化工具，例如序列化、RFID 标籤和云端追溯系统，以满足客户对生产历史和合规性文件的可视性需求。

为了增强诊断包装的韧性、合规性和客户协作，我们将实施一体化供应多元化，扩大区域生产能力，并引入数位追溯。

产业领导企业可以透过实施一系列重点措施，将颠覆性变革转化为竞争优势。优先考虑供应商网路多元化和关键材料的双重采购，以降低贸易政策波动和区域生产限制带来的风险，同时确保材料之间具有经验检验的等效性。投资区域无菌填充和二次包装产能，以缩短前置作业时间和降低关税风险，并将这些投资与无菌​​检验计划相结合，以确保符合法规要求。将特殊聚合物选项和检验的层压结构纳入产品系列，以满足常温、冷藏和冷冻应用场景中的热性能和阻隔性能需求，同时推进可衡量的永续性目标。

严谨的混合方法研究途径结合了相关人员访谈、技术审查和交叉检验的案例研究，以得出有关包装技术及其应用的可操作见解。

本调查方法结合了第一手和第二手研究手段，旨在深入了解诊断包装的现状。第一手研究包括对诊断检查室、医院和诊所、就地检验提供者以及研究机构的包装工程师、供应链经理、法规遵循专家和采购经理进行结构化访谈，以了解其营运重点和验证实践。第二手研究则包括对法规指南、技术标准、专利趋势、製造案例研究和科学文献的深入分析，以全面检验材料在常温、冷藏和冷冻运输中的性能、无菌加工趋势以及低温运输要求。

对无菌处理、材料合格和数位化追溯进行协调投资，对于确保诊断的完整性和营运的韧性至关重要。

製造创新、材料科学、监管进步和贸易政策调整正在共同建构体外诊断医疗设备包装领域的新营运模式。包装日益被视为一项策略性资产，它能够保障诊断准确性、提升供应链弹性并支持永续性。那些将无菌生产能力、特种材料和数位化可追溯性方面的投资与区域优化製造地相结合的企业，将更有能力应对关税波动，并满足诊断检查室、医院和诊所、就地检验技术人员以及研究机构的多元化需求。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：体外诊断试剂包装市场（依包装类型划分）

  • 吹灌密封
    • 安瓿
    • 墨水匣和磁带
  • 软包装
    • 薄膜和层压
    • 收纳袋
  • 硬包装
    • 微孔盘和玻片
    • 试管管瓶

第九章：体外诊断试剂包装市场：依材料分类

  • 玻璃
  • 塑胶
  • 特种聚合物
  • 永续材料

第十章：体外诊断试剂包装市场（依灭菌状态划分）

  • 非无菌
  • 已灭菌

第十一章：体外诊断试剂包装市场（依温度要求划分）

  • 环境的
  • 冷冻
  • 冷藏

第十二章：体外诊断试剂包装市场：依最终用户划分

  • 诊断检查室
  • 医院和诊所
  • 即时检测
  • 研究机构

第十三章：体外诊断试剂包装市场：依通路划分

  • 直销
  • 销售代理
  • 在线的

第十四章：体外诊断试剂包装市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十五章：体外诊断试剂包装市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十六章：体外诊断试剂包装市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十七章：美国体外诊断包装市场

第十八章：中国体外诊断医疗器材包装市场

第十九章 竞争情势

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Amcor PLC
  • APTARGROUP, INC.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Corning Incorporated
  • DWK Life Sciences GmbH
  • DWK Life Sciences LLC
  • James Alexander Corporation
  • Narang Medical Limited
  • Oliver-Tolas Healthcare Packaging BV
  • PerkinElmer Inc.
  • PMMI Media Group
  • QIAGEN NV
  • Siemens AG
  • SONIC PACKAGING
  • Thermofisher Scientific Inc.
  • VITLAB GmbH
Product Code: MRR-F6513A06BD97

The In-Vitro Diagnostics Packaging Market was valued at USD 8.21 billion in 2025 and is projected to grow to USD 8.76 billion in 2026, with a CAGR of 7.07%, reaching USD 13.25 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 8.21 billion
Estimated Year [2026] USD 8.76 billion
Forecast Year [2032] USD 13.25 billion
CAGR (%) 7.07%

A strategic orientation toward integrity, traceability, and sustainability is reshaping how diagnostic packaging supports clinical workflows and regulatory expectations

The in-vitro diagnostics packaging landscape stands at a pivotal juncture driven by accelerating innovation, heightened regulatory scrutiny, and an intensified emphasis on supply chain resilience. Packaging functions no longer serve solely as containment and protection; they underpin diagnostic accuracy, biosafety, and traceability across the specimen lifecycle. As laboratories, hospitals, point-of-care providers, and research institutions expand testing modalities, the demand profile for packaging solutions has diversified rapidly. This transformation compels manufacturers and procurement teams to rethink material choices, aseptic processing, and end-to-end cold chain capabilities to maintain sample integrity and ensure patient safety.

Concurrently, sustainability ambitions and circular-economy objectives are influencing material selection and end-of-life considerations. Advances in specialty polymers and recyclable substrates are converging with legacy materials like glass and traditional plastics, prompting stakeholders to weigh performance against environmental impact. Regulatory authorities are also refining expectations for sterility validation and labeling, which further elevates the role of packaging as a compliance instrument. The combined effect of these forces requires cross-functional collaboration between packaging engineers, quality and regulatory teams, and commercial stakeholders to create robust, scalable solutions that meet clinical and operational realities.

Integrated manufacturing, advanced materials, and digital traceability are converging to redefine packaging's role in diagnostic accuracy, logistics, and procurement channels

The sector is experiencing transformative shifts that reconfigure competitive dynamics and operational priorities. Advances in aseptic processing technologies such as blow-fill-seal systems and integrated cartridge production are enabling higher throughput with reduced contamination risk, while flexible packaging innovations are optimizing transport weight and storage efficiency. These process-level innovations are complemented by materials science breakthroughs: specialty polymers and formulation-stable laminates are improving barrier properties and thermal tolerance, enabling expanded use cases across ambient, refrigerated, and frozen temperature requirements. As a result, packaging is evolving from passive protection to an active enabler of diagnostic performance and logistics efficiency.

Market participants are also adapting to an omnichannel procurement environment. Direct sales relationships coexist with distributor networks and online platforms, reshaping go-to-market strategies and customer engagement models. This shift drives demand for standardized technical dossiers and digital assets that support remote evaluation and qualification. Additionally, digital traceability systems and serialization are becoming expected features for high-value or regulated diagnostic shipments, creating new interoperability challenges and data governance obligations. Together, these shifts demand integrated roadmaps that align manufacturing capability, materials sourcing, and digital infrastructure to preserve product quality while improving cost and time efficiencies.

Tariff adjustments and trade policy changes have catalyzed supply chain realignment and regional production investments to protect diagnostic packaging continuity and compliance

The imposition of tariffs and trade policy adjustments in the United States during 2025 has exerted measurable pressure across inbound raw materials and finished diagnostic packaging imports, prompting rapid strategic responses from manufacturers and buyers alike. Tariff-driven cost escalation accelerated the reassessment of supplier footprints and contractual terms, particularly for components and substrates sourced from global supply nodes. This environment has increased the urgency for supply chain mapping, supplier risk assessments, and the identification of alternative raw material options that maintain barrier performance and sterility assurance without compromising regulatory compliance.

In response, many organizations have pursued nearshoring or dual-sourcing strategies to mitigate exposure to tariff volatility and cross-border customs delays. These moves often entail capital investment in regional aseptic filling and packaging capabilities, as well as renegotiation of logistics arrangements to preserve cold-chain integrity for refrigerated and frozen shipments. Price pressures have driven tighter inventory management, a shift toward longer-term supplier agreements with tariff pass-through clauses, and the acceleration of supplier qualification processes to shorten lead times. Policymakers' actions also incentivized collaboration between industry and regulators to clarify classification, harmonize certification requirements, and expedite customs processes for critical diagnostic supplies, which has reduced clearance uncertainty even as duty costs remain a factor in procurement decisions.

Granular segmentation across format, material, end-user, sterility, temperature, and distribution reveals targeted product and go-to-market imperatives for diagnostic packaging

Segmentation reveals differentiated demand patterns and technical requirements that inform product development and commercialization strategies. Packaging format dynamics show that blow-fill-seal solutions, particularly ampoules and cartridges & cassettes, are favored where sterility, precision dosing, and integrated filling are critical, while flexible packaging such as film & laminates and pouches & bags supports high-volume reagent distribution and lightweight transport. Rigid packaging categories, encompassing microplates & slides and tubes & vials, remain central to laboratory automation and sample storage, with ongoing optimization for ergonomic handling and instrument compatibility.

Material selection strongly shapes performance and environmental outcomes, with traditional glass persisting in high-purity applications while plastics deliver impact resistance and design flexibility. Specialty polymers have emerged to fulfill demanding barrier and thermal profiles, and sustainable materials are increasingly incorporated to address end-of-life and procurement sustainability mandates. End users drive divergent packaging requirements: diagnostic laboratories prioritize automation compatibility and throughput; hospitals and clinics value sterility, clinician usability, and storage efficiency; point-of-care testing demands compact, robust, and easy-to-use formats; research institutes seek customizable formats for experimental workflows. Sterility requirements bifurcate solutions between sterile and non-sterile applications, each with distinct validation and handling workflows. Temperature requirements create separate value chains for ambient, frozen, and refrigerated shipments, influencing material choices and secondary packaging. Finally, distribution channels-direct sales, distributors, and online-shape customer experience, qualification timelines, and aftermarket support, necessitating tailored service and technical documentation for each route to market.

Regional differences in regulatory priorities, manufacturing capacity, and cold chain maturity are shaping divergent strategic approaches to diagnostic packaging deployment

Regional dynamics underscore heterogeneous priorities that influence manufacturing footprint, regulatory strategies, and logistics investment. In the Americas, demand concentrates on advanced laboratory infrastructure and point-of-care rollout, creating robust uptake for sterile, automation-ready rigid formats and a sustained need for refrigerated and ambient solutions. The region's regulatory landscape and procurement cycles encourage investments in domestic or nearshore production, particularly where policy shifts increase the cost of imports or prioritize supply security.

Europe, the Middle East and Africa present a mosaic of regulatory stringency and sustainability focus. Western European markets emphasize material recyclability, extended producer responsibility, and tight sterility controls, which in turn accelerate adoption of specialty polymers and validated sterilization pathways. In EMEA markets where centralized lab networks coexist with decentralized testing, packaging solutions must balance cost-efficiency with traceability and compatibility across diverse cold chain infrastructures. The Asia-Pacific region combines large-scale manufacturing capacity, rapidly expanding diagnostic access, and divergent logistics maturity. Strong production clusters in the region enable competitive sourcing of both glass and polymer formats, but heterogeneity in cold chain and regulatory harmonization requires localized validation strategies and adaptable packaging designs to meet varied end-user needs.

Companies are reinforcing aseptic capability, materials innovation, and digital traceability while expanding service bundles and regional production to secure competitive advantage

Leading companies in the diagnostic packaging space are pursuing an array of competitive strategies that combine technological investment with commercial realignment. Many are deepening capabilities in aseptic processing and blow-fill-seal systems to reduce contamination risk and accelerate throughput for sterile single-use products. Simultaneously, materials innovation programs target specialty polymers and laminate constructions that improve barrier and thermal stability while enabling recyclability or reduced material mass. Firms are also investing in digital tools such as serialization, RFID tagging, and cloud-enabled traceability to meet customer demands for chain-of-custody visibility and compliance documentation.

Commercially, players are expanding service offerings that pair packaging with analytical support, qualification packs, and regulatory dossiers to simplify customer adoption and shorten qualification cycles. Strategic partnerships and targeted acquisitions have become common to access niche capabilities, scale manufacturing, and extend distribution networks. In parallel, quality and regulatory teams within these companies are enhancing sterility validation protocols and cold chain qualification to support refrigerated and frozen shipments, reflecting the broader market emphasis on preserving sample integrity across diverse temperature requirements. Together, these initiatives signal a surge in vertically integrated approaches that combine materials expertise, aseptic manufacturing, and aftermarket services to reinforce competitive differentiation.

Adopt integrated supply diversification, regional capacity buildouts, and digital traceability to strengthen resilience, compliance, and customer alignment in diagnostic packaging

Industry leaders can adopt a focused set of actions to convert disruption into advantage. Prioritize diversified supplier networks and dual-source critical substrates to mitigate exposure to trade policy shifts and regional production constraints while maintaining validated equivalency across materials. Invest in regional aseptic filling and secondary packaging capacity to reduce lead times and tariff exposure, and align those investments with sterility validation programs to ensure regulatory readiness. Incorporate specialty polymer options and validated laminate constructions into product portfolios to address thermal and barrier needs across ambient, refrigerated, and frozen use cases while also advancing measurable sustainability goals.

Enhance digital capabilities by deploying serialization and real-time traceability systems that integrate with customer laboratory information management systems and distribution partners. Tailor go-to-market models for different channels: strengthen direct sales engagement for strategic accounts, streamline qualification kits and technical documentation for distributors, and optimize digital assets and e-commerce capabilities for online procurement. Pair technology investments with commercial incentives such as flexible contract terms and inventory consignment models to stabilize supply for key end users like diagnostic laboratories, hospitals and clinics, point-of-care providers, and research institutes. Finally, institutionalize cross-functional decision-making processes that bring procurement, quality, regulatory, and operations together to accelerate supplier qualification, change control, and new product introductions.

A rigorous mixed-methods research approach blended stakeholder interviews, technical reviews, and cross-validated case analyses to produce actionable insights into packaging technologies and adoption

The research methodology combined primary and secondary investigative approaches to produce an evidence-based view of the diagnostic packaging landscape. Primary research incorporated structured interviews with packaging engineers, supply chain leaders, regulatory affairs specialists, and procurement heads across diagnostic laboratories, hospitals and clinics, point-of-care testing providers, and research institutes to capture operational priorities and validation practices. Secondary investigation reviewed regulatory guidances, technical standards, patent activity, manufacturing case studies, and scientific literature to triangulate material performance, aseptic processing trends, and cold chain requirements for ambient, refrigerated, and frozen shipments.

Data validation and synthesis involved cross-referencing interview insights with manufacturing and logistics case examples, ensuring that material choices and format preferences reflect real-world adoption patterns. Segment-level analysis was informed by format-specific technical comparisons-examining blow-fill-seal ampoules and cartridges & cassettes, flexible film & laminate constructions and pouches & bags, as well as rigid microplates & slides alongside tubes & vials-while mapping material properties across glass, plastic, specialty polymers, and sustainable materials. The methodology also evaluated distribution channel behaviors across direct sales, distributors, and online platforms to reflect procurement realities. Limitations include variations in regional regulations and the pace of technology adoption, which were mitigated by validating findings with multiple stakeholders and prioritizing conservative interpretation where practices diverged significantly.

Coordinated investments in aseptic processing, materials qualification, and digital traceability are critical to secure diagnostic integrity and operational resilience

The convergence of manufacturing innovation, materials science, regulatory evolution, and trade policy adjustments is setting a new operating paradigm for in-vitro diagnostics packaging. Packaging is increasingly recognized as a strategic asset that safeguards diagnostic fidelity, enables supply chain agility, and supports sustainability commitments. Organizations that align investments in aseptic capabilities, specialty materials, and digital traceability with regionally optimized manufacturing footprints will be best positioned to manage tariff-driven volatility and fulfill the nuanced needs of diagnostic laboratories, hospitals and clinics, point-of-care testers, and research institutes.

Moving forward, success will depend on the ability to execute coordinated strategies that integrate product development, regulatory planning, and commercial deployment. Stakeholders that institutionalize supplier diversification, accelerate material qualification protocols, and deploy traceability systems will reduce operational risk while improving time-to-market. In short, proactive alignment of technical capability and commercial strategy is the most reliable path to preserving sample integrity, meeting evolving regulatory demands, and capturing the strategic benefits that flow from a resilient, future-ready packaging ecosystem.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. In-Vitro Diagnostics Packaging Market, by Packaging Format

  • 8.1. Blow-Fill-Seal
    • 8.1.1. Ampoules
    • 8.1.2. Cartridges & Cassettes
  • 8.2. Flexible Packaging
    • 8.2.1. Film & Laminates
    • 8.2.2. Pouches & Bags
  • 8.3. Rigid Packaging
    • 8.3.1. Microplates & Slides
    • 8.3.2. Tubes & Vials

9. In-Vitro Diagnostics Packaging Market, by Material

  • 9.1. Glass
  • 9.2. Plastic
  • 9.3. Specialty Polymers
  • 9.4. Sustainable Materials

10. In-Vitro Diagnostics Packaging Market, by Sterility

  • 10.1. Non-Sterile
  • 10.2. Sterile

11. In-Vitro Diagnostics Packaging Market, by Temperature Requirement

  • 11.1. Ambient
  • 11.2. Frozen
  • 11.3. Refrigerated

12. In-Vitro Diagnostics Packaging Market, by End User

  • 12.1. Diagnostic Laboratories
  • 12.2. Hospitals & Clinics
  • 12.3. Point-Of-Care Testing
  • 12.4. Research Institutes

13. In-Vitro Diagnostics Packaging Market, by Distribution Channel

  • 13.1. Direct Sales
  • 13.2. Distributors
  • 13.3. Online

14. In-Vitro Diagnostics Packaging Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. In-Vitro Diagnostics Packaging Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. In-Vitro Diagnostics Packaging Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States In-Vitro Diagnostics Packaging Market

18. China In-Vitro Diagnostics Packaging Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Amcor PLC
  • 19.6. APTARGROUP, INC.
  • 19.7. Becton, Dickinson and Company
  • 19.8. Bio-Rad Laboratories, Inc.
  • 19.9. Corning Incorporated
  • 19.10. DWK Life Sciences GmbH
  • 19.11. DWK Life Sciences LLC
  • 19.12. James Alexander Corporation
  • 19.13. Narang Medical Limited
  • 19.14. Oliver-Tolas Healthcare Packaging B.V.
  • 19.15. PerkinElmer Inc.
  • 19.16. PMMI Media Group
  • 19.17. QIAGEN N.V.
  • 19.18. Siemens AG
  • 19.19. SONIC PACKAGING
  • 19.20. Thermofisher Scientific Inc.
  • 19.21. VITLAB GmbH

LIST OF FIGURES

  • FIGURE 1. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PACKAGING FORMAT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY STERILITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PACKAGING FORMAT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY BLOW-FILL-SEAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY BLOW-FILL-SEAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY BLOW-FILL-SEAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY BLOW-FILL-SEAL, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY AMPOULES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY AMPOULES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY AMPOULES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY CARTRIDGES & CASSETTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY CARTRIDGES & CASSETTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY CARTRIDGES & CASSETTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY FLEXIBLE PACKAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY FLEXIBLE PACKAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY FLEXIBLE PACKAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY FLEXIBLE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY FILM & LAMINATES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY FILM & LAMINATES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY FILM & LAMINATES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY POUCHES & BAGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY POUCHES & BAGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY POUCHES & BAGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY RIGID PACKAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY RIGID PACKAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY RIGID PACKAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY RIGID PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY MICROPLATES & SLIDES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY MICROPLATES & SLIDES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY MICROPLATES & SLIDES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY TUBES & VIALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY TUBES & VIALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY TUBES & VIALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY GLASS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY GLASS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY GLASS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PLASTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PLASTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PLASTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY SPECIALTY POLYMERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY SPECIALTY POLYMERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY SPECIALTY POLYMERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY SUSTAINABLE MATERIALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY SUSTAINABLE MATERIALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY SUSTAINABLE MATERIALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY STERILITY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY NON-STERILE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY NON-STERILE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY NON-STERILE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY STERILE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY STERILE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY STERILE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY AMBIENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY AMBIENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY AMBIENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY FROZEN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY FROZEN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY FROZEN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY REFRIGERATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY REFRIGERATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY REFRIGERATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY POINT-OF-CARE TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY POINT-OF-CARE TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY POINT-OF-CARE TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. AMERICAS IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 88. AMERICAS IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PACKAGING FORMAT, 2018-2032 (USD MILLION)
  • TABLE 89. AMERICAS IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY BLOW-FILL-SEAL, 2018-2032 (USD MILLION)
  • TABLE 90. AMERICAS IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY FLEXIBLE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 91. AMERICAS IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY RIGID PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 92. AMERICAS IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 93. AMERICAS IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY STERILITY, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 97. NORTH AMERICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. NORTH AMERICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PACKAGING FORMAT, 2018-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY BLOW-FILL-SEAL, 2018-2032 (USD MILLION)
  • TABLE 100. NORTH AMERICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY FLEXIBLE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 101. NORTH AMERICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY RIGID PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 102. NORTH AMERICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY STERILITY, 2018-2032 (USD MILLION)
  • TABLE 104. NORTH AMERICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 107. LATIN AMERICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. LATIN AMERICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PACKAGING FORMAT, 2018-2032 (USD MILLION)
  • TABLE 109. LATIN AMERICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY BLOW-FILL-SEAL, 2018-2032 (USD MILLION)
  • TABLE 110. LATIN AMERICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY FLEXIBLE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 111. LATIN AMERICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY RIGID PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 112. LATIN AMERICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY STERILITY, 2018-2032 (USD MILLION)
  • TABLE 114. LATIN AMERICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2018-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PACKAGING FORMAT, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY BLOW-FILL-SEAL, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY FLEXIBLE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY RIGID PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY STERILITY, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PACKAGING FORMAT, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY BLOW-FILL-SEAL, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY FLEXIBLE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY RIGID PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY STERILITY, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 137. MIDDLE EAST IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. MIDDLE EAST IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PACKAGING FORMAT, 2018-2032 (USD MILLION)
  • TABLE 139. MIDDLE EAST IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY BLOW-FILL-SEAL, 2018-2032 (USD MILLION)
  • TABLE 140. MIDDLE EAST IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY FLEXIBLE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 141. MIDDLE EAST IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY RIGID PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 142. MIDDLE EAST IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 143. MIDDLE EAST IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY STERILITY, 2018-2032 (USD MILLION)
  • TABLE 144. MIDDLE EAST IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2018-2032 (USD MILLION)
  • TABLE 145. MIDDLE EAST IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 147. AFRICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. AFRICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PACKAGING FORMAT, 2018-2032 (USD MILLION)
  • TABLE 149. AFRICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY BLOW-FILL-SEAL, 2018-2032 (USD MILLION)
  • TABLE 150. AFRICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY FLEXIBLE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 151. AFRICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY RIGID PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 152. AFRICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 153. AFRICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY STERILITY, 2018-2032 (USD MILLION)
  • TABLE 154. AFRICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2018-2032 (USD MILLION)
  • TABLE 155. AFRICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 156. AFRICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PACKAGING FORMAT, 2018-2032 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY BLOW-FILL-SEAL, 2018-2032 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY FLEXIBLE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 161. ASIA-PACIFIC IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY RIGID PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 162. ASIA-PACIFIC IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY STERILITY, 2018-2032 (USD MILLION)
  • TABLE 164. ASIA-PACIFIC IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2018-2032 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 167. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 168. ASEAN IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. ASEAN IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PACKAGING FORMAT, 2018-2032 (USD MILLION)
  • TABLE 170. ASEAN IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY BLOW-FILL-SEAL, 2018-2032 (USD MILLION)
  • TABLE 171. ASEAN IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY FLEXIBLE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 172. ASEAN IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY RIGID PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 173. ASEAN IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 174. ASEAN IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY STERILITY, 2018-2032 (USD MILLION)
  • TABLE 175. ASEAN IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2018-2032 (USD MILLION)
  • TABLE 176. ASEAN IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 177. ASEAN IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 178. GCC IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 179. GCC IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PACKAGING FORMAT, 2018-2032 (USD MILLION)
  • TABLE 180. GCC IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY BLOW-FILL-SEAL, 2018-2032 (USD MILLION)
  • TABLE 181. GCC IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY FLEXIBLE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 182. GCC IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY RIGID PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 183. GCC IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 184. GCC IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY STERILITY, 2018-2032 (USD MILLION)
  • TABLE 185. GCC IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2018-2032 (USD MILLION)
  • TABLE 186. GCC IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 187. GCC IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPEAN UNION IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPEAN UNION IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PACKAGING FORMAT, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPEAN UNION IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY BLOW-FILL-SEAL, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPEAN UNION IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY FLEXIBLE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPEAN UNION IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY RIGID PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPEAN UNION IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPEAN UNION IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY STERILITY, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPEAN UNION IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPEAN UNION IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPEAN UNION IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 198. BRICS IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 199. BRICS IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PACKAGING FORMAT, 2018-2032 (USD MILLION)
  • TABLE 200. BRICS IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY BLOW-FILL-SEAL, 2018-2032 (USD MILLION)
  • TABLE 201. BRICS IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY FLEXIBLE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 202. BRICS IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY RIGID PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 203. BRICS IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 204. BRICS IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY STERILITY, 2018-2032 (USD MILLION)
  • TABLE 205. BRICS IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2018-2032 (USD MILLION)
  • TABLE 206. BRICS IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 207. BRICS IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 208. G7 IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 209. G7 IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PACKAGING FORMAT, 2018-2032 (USD MILLION)
  • TABLE 210. G7 IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY BLOW-FILL-SEAL, 2018-2032 (USD MILLION)
  • TABLE 211. G7 IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY FLEXIBLE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 212. G7 IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY RIGID PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 213. G7 IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 214. G7 IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY STERILITY, 2018-2032 (USD MILLION)
  • TABLE 215. G7 IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2018-2032 (USD MILLION)
  • TABLE 216. G7 IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 217. G7 IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 218. NATO IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 219. NATO IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PACKAGING FORMAT, 2018-2032 (USD MILLION)
  • TABLE 220. NATO IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY BLOW-FILL-SEAL, 2018-2032 (USD MILLION)
  • TABLE 221. NATO IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY FLEXIBLE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 222. NATO IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY RIGID PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 223. NATO IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 224. NATO IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY STERILITY, 2018-2032 (USD MILLION)
  • TABLE 225. NATO IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2018-2032 (USD MILLION)
  • TABLE 226. NATO IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 227. NATO IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 228. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 229. UNITED STATES IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 230. UNITED STATES IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PACKAGING FORMAT, 2018-2032 (USD MILLION)
  • TABLE 231. UNITED STATES IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY BLOW-FILL-SEAL, 2018-2032 (USD MILLION)
  • TABLE 232. UNITED STATES IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY FLEXIBLE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 233. UNITED STATES IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY RIGID PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 234. UNITED STATES IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 235. UNITED STATES IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY STERILITY, 2018-2032 (USD MILLION)
  • TABLE 236. UNITED STATES IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2018-2032 (USD MILLION)
  • TABLE 237. UNITED STATES IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 238. UNITED STATES IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 239. CHINA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 240. CHINA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PACKAGING FORMAT, 2018-2032 (USD MILLION)
  • TABLE 241. CHINA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY BLOW-FILL-SEAL, 2018-2032 (USD MILLION)
  • TABLE 242. CHINA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY FLEXIBLE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 243. CHINA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY RIGID PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 244. CHINA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 245. CHINA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY STERILITY, 2018-2032 (USD MILLION)
  • TABLE 246. CHINA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2018-2032 (USD MILLION)
  • TABLE 247. CHINA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 248. CHINA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)